Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore.
Foreign fund house Morgan Stanley Asia Singapore today offloaded 17.32 lakh shares of Aurobindo Pharma for Rs 116 crore through an open market transaction.
In a separate transaction, Abu Dhabi Investment Authority picked up 14.75 lakh shares of the pharmaceutical firm for an estimated amount of nearly Rs 99 crore, bulk deal details with the stock exchanges showed.
Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore.
Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma representing 1.58 percent stake in the company as on March 31, 2014.
Aurobindo Pharma has been included in the MSCI Global Standard Indices from today. Shares of Aurobindo Pharma rose 4.76 percent to end the day at Rs 667.70 apiece on the BSE.
Aurobindo Pharm stock price
On May 30, 2014, Aurobindo Pharma closed at Rs 667.70, up Rs 30.35, or 4.76 percent. The 52-week high of the share was Rs 678.40 and the 52-week low was Rs 138.45.
The company's trailing 12-month (TTM) EPS was at Rs 31.05 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 21.5. The latest book value of the company is Rs 100.84 per share. At current value, the price-to-book value of the company is 6.62.
Anda sedang membaca artikel tentang
Morgan Stanley sells Aurobindo Pharma shares worth Rs 116cr
Dengan url
http://gayafashionshow.blogspot.com/2014/05/morgan-stanley-sells-aurobindo-pharma.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Morgan Stanley sells Aurobindo Pharma shares worth Rs 116cr
namun jangan lupa untuk meletakkan link
Morgan Stanley sells Aurobindo Pharma shares worth Rs 116cr
sebagai sumbernya
0 komentar:
Posting Komentar